Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)

Hiroshi Nishiura, Hitoshi Oshitani, Tetsuro Kobayashi, Tomoya Saito, Tomimasa Sunagawa, Tamano Matsui, Takaji Wakita, MHLW COVID-19 Response Team, Motoi Suzuki
doi: https://doi.org/10.1101/2020.02.28.20029272
Hiroshi Nishiura
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
2Graduate School of Medicine, Hokkaido University, Kia 15 Jo Nishi 7 Chome, Kitaku, Sapporo, 060-8638, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nishiurah{at}med.hokudai.ac.jp
Hitoshi Oshitani
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
3Tohoku University Graduate School of Medicine, Seiryocho 2-1, Aoba-ku, Sendai, 980-8575, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuro Kobayashi
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
2Graduate School of Medicine, Hokkaido University, Kia 15 Jo Nishi 7 Chome, Kitaku, Sapporo, 060-8638, Japan
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoya Saito
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
4National Institute of Public Health, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
M.D., M.P.H., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomimasa Sunagawa
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
5National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tamano Matsui
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
5National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takaji Wakita
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
5National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
Motoi Suzuki
1Cluster Intervention Group, Ministry of Health, Labour and Welfare, Kasumigaseki 1-2-2, Chiyoda-ku, Tokyo 100-8916, Japan
5National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective To identify common features of cases with novel coronavirus disease (COVID-19) so as to better understand what factors promote secondary transmission including superspreading events.

Methods A total of 110 cases were examined among eleven clusters and sporadic cases, and investigated who acquired infection from whom. The clusters included four in Tokyo and one each in Aichi, Fukuoka, Hokkaido, Ishikawa, Kanagawa and Wakayama prefectures. The number of secondary cases generated by each primary case was calculated using contact tracing data.

Results Of the 110 cases examined, 27 (24.6%) were primary cases who generated secondary cases. The odds that a primary case transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment (95% confidence interval [CI]: 6.0, 57.9).

Conclusions It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events. Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease.

Introduction

Although the incidence of coronavirus disease 2019 (COVID-19) in China began to decrease in February 2020,1 many countries are struggling with containment of the disease. To effectively reduce the spread of COVID-19, it is vital to identify common features of cases so as to better understand what factors promote superspreading events,2 wherein an extraordinarily large number of secondary transmissions are produced by a single primary case. Commissioned by the Minister of the Ministry of Health, Labour, and Welfare of Japan, we collected secondary transmission data with the aim of identifying high risk transmission settings.

Methods

As of 28 February 2020,3 we examined a total of 110 cases among eleven clusters and sporadic cases, and investigated who acquired infection from whom. The clusters included four in Tokyo and one each in Aichi, Fukuoka, Hokkaido, Ishikawa, Kanagawa and Wakayama prefectures. All traced transmission events were examined in relation to close contact in indoor environments, including fitness gyms, a restaurant boat on a river, hospitals, and a snow festival where there were eating spaces in tents with minimal ventilation rate. The number of secondary cases generated by each primary case was calculated using contact tracing data.

Results

Of the 110 cases examined, 27 (24.6%) were primary cases who generated secondary cases. Figure 1 shows the distribution of these transmissions, of which the mean and variance were 0.6 cases and 2.5 cases2, respectively. The odds that a primary case transmitted COVID-19 in a closed environment was 18.7 times greater compared to an open-air environment (95% confidence interval [CI]: 6.0, 57.9).

Figure 1.
  • Download figure
  • Open in new tab
Figure 1.

The distribution of the number of secondary cases generated by a single primary case with novel coronavirus (COVID-19). The mean and variance were 0.6 cases and 2.5 cases2, respectively.

If superspreading events are defined as events where the number of secondary cases generated by a single primary case is greater than the 95th percentile of the distribution (i.e. transmission to three or more persons), then seven of the 110 cases (6.4%) were involved in such events. Six of these events (85.7%) took place in closed environments, and the odds ratio (OR) of superspreading events in closed environments was as high as 32.6 (95% CI: 3.7, 289.5).

Discussion

It is plausible that closed environments contribute to secondary transmission of COVID-19 and promote superspreading events. Closed environments are consistent with environmental sampling study4 and also large-scale COVID-19 transmission events such as that of the ski chalet-associated cluster in France and the church- and hospital-associated clusters in South Korea5. Our findings are also consistent with the declining incidence of COVID-19 cases in China, as gathering in closed environments was prohibited in the wake of the rapid spread of the disease.

Reduction of unnecessary close contact in closed environments may help prevent large case clusters and superspreading events. We hope that with such a reduction in contact the reproduction number of COVID-19 in Japan will be maintained below 1 and contact tracing will be sufficient to contain disease spread.6 As the possibility of confounders and interactions was not assessed in this study, additional studies must be conducted to verify the importance of closed environments as facilitators for transmission of COVID-19.

Data Availability

Anonymized dataset will be provided by the corresponding author upon request.

Conflict of interest

We declare that we have no conflict of interest.

Acknowledgement

We sincerely thank staff of local governments, including health centers and prefectural institutes of public health, healthcare facilities, and associated companies and organizations for cooperating us to collect and investigate secondary transmission data. H.N. received funding support from Japan Agency for Medical Research and Development [grant number: JP18fk0108050] and the Japan Science and Technology Agency (JST) Core Research for Evolutional Science and Technology (CREST) program [grant number: JPMJCR1413].

References

  1. 1.↵
    The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020. China CDC Weekly 2020;2(8):113–122.
    OpenUrl
  2. 2.↵
    Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Superspreading and the effect of individual variation on disease emergence. Nature 2005;438:355–359.
    OpenUrlCrossRefPubMedWeb of Science
  3. 3.↵
    Ministry of Health, Labour and Welfare, Japan. On the novel coronavirus infection. Tokyo: Ministry of Health, Labour and Welfare, 2020. Available online from: https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000164708_00001.html (accessed on 26 February 2020).
  4. 4.↵
    Ong SWX, Tan YK, Chia PY, Lee TH, Ng OT, Wong MSY, Marimuthu K. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020; in press. doi: 10.1001/jama.2020.3227.
    OpenUrlCrossRefPubMed
  5. 5.↵
    Promed mail. Subject: PRO/AH/EDR> COVID-19 update (19): China, global, Italy & Iran. imported cases, WHO. Archive Number: 20200226.70298421
  6. 6.↵
    Grantz K, Metcalf JE, Lessler J. Dispersion vs. control. 2020. Available online from: https://hopkinsidd.github.io/nCoV-Sandbox/DispersionExploration.html (accessed on 26 February 2020).
Back to top
PreviousNext
Posted April 16, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)
Hiroshi Nishiura, Hitoshi Oshitani, Tetsuro Kobayashi, Tomoya Saito, Tomimasa Sunagawa, Tamano Matsui, Takaji Wakita, MHLW COVID-19 Response Team, Motoi Suzuki
medRxiv 2020.02.28.20029272; doi: https://doi.org/10.1101/2020.02.28.20029272
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Closed environments facilitate secondary transmission of coronavirus disease 2019 (COVID-19)
Hiroshi Nishiura, Hitoshi Oshitani, Tetsuro Kobayashi, Tomoya Saito, Tomimasa Sunagawa, Tamano Matsui, Takaji Wakita, MHLW COVID-19 Response Team, Motoi Suzuki
medRxiv 2020.02.28.20029272; doi: https://doi.org/10.1101/2020.02.28.20029272

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (434)
  • Allergy and Immunology (760)
  • Anesthesia (222)
  • Cardiovascular Medicine (3316)
  • Dentistry and Oral Medicine (366)
  • Dermatology (282)
  • Emergency Medicine (480)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1175)
  • Epidemiology (13403)
  • Forensic Medicine (19)
  • Gastroenterology (900)
  • Genetic and Genomic Medicine (5182)
  • Geriatric Medicine (483)
  • Health Economics (786)
  • Health Informatics (3286)
  • Health Policy (1146)
  • Health Systems and Quality Improvement (1199)
  • Hematology (432)
  • HIV/AIDS (1024)
  • Infectious Diseases (except HIV/AIDS) (14657)
  • Intensive Care and Critical Care Medicine (917)
  • Medical Education (478)
  • Medical Ethics (128)
  • Nephrology (526)
  • Neurology (4957)
  • Nursing (263)
  • Nutrition (735)
  • Obstetrics and Gynecology (889)
  • Occupational and Environmental Health (797)
  • Oncology (2531)
  • Ophthalmology (730)
  • Orthopedics (284)
  • Otolaryngology (348)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (547)
  • Pediatrics (1308)
  • Pharmacology and Therapeutics (552)
  • Primary Care Research (559)
  • Psychiatry and Clinical Psychology (4225)
  • Public and Global Health (7526)
  • Radiology and Imaging (1717)
  • Rehabilitation Medicine and Physical Therapy (1022)
  • Respiratory Medicine (982)
  • Rheumatology (480)
  • Sexual and Reproductive Health (500)
  • Sports Medicine (425)
  • Surgery (551)
  • Toxicology (73)
  • Transplantation (237)
  • Urology (206)